Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 10, keine Gesamtzahl für „section“
Suchtreffer
Begriffe & Kennungen
Avonex · 4.8 · rare nephrotic syndrome, glomerulosclerosis (see section 4.4 ‘special warnings and precautions’) Endocrine dis
Eintrag öffnenAwiqli · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAwiqli · 4.8 · For information on daily basal insulin comparators used in each trial, please see section 5.1.
Eintrag öffnenAwiqli · 4.8 · See also section 5.1.
Eintrag öffnenAxumin · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1
Eintrag öffnenAxura · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAxura · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAzacitidine Mylan · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Advanced malignant
Eintrag öffnenAzarga · 4.3 · • Hypersensitivity to the active substances or to any of the excipients listed in section 6.1. • Hypersensitiv
Eintrag öffnenAzilect · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenAzilect · 4.5 · The concomitant use of rasagiline and fluoxetine or fluvoxamine should be avoided (see section 4.4).
Eintrag öffnenAzomyr · 4.3 · Hypersensitivity to the active substance, to any of the excipients listed in section 6.1, or to loratadine.
Eintrag öffnenAzomyr · 4.3 · Hypersensitivity to the active substance, to any of the excipients listed in section 6.1, or to loratadine.
Eintrag öffnenAzopt · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Known hypersen
Eintrag öffnenBaiama · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Active or susp
Eintrag öffnenBaiama · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Active or susp
Eintrag öffnenBalversa · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenBaraclude · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenBaraclude · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenBaraclude · 4.5 · Entecavir is not a substrate, an inducer or an inhibitor of cytochrome P450 (CYP450) enzymes (see section 5.2)
Eintrag öffnen